Adlai Nortye ANL
NASDAQ ANL
$15.65 +0.25 (+1.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Payables (2022 - 2026)

Updated

Adlai Nortye (ANL) reported Payables of $22.23 million for Q2 2026, down 58.6% from $53.73 million a year earlier.

Analysis

Adlai Nortye (ANL) Payables (2022 - 2026) Analysis & Trends

At the end of FY2025, Adlai Nortye posted Payables of $37.22 million, up 2.0% from FY2024.

  • Payables has a three-year compound annual growth rate of 28.8% (FY2022 to FY2025).
  • By year, Payables came in at $36.48 million in FY2024 (-18.4%), $44.71 million in FY2023 (+156.9%) and $17.41 million in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly Payables since Q4 2023.
  • Year over year, Payables gained in three of the last four quarters, with growth averaging 29.1%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 20.92 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.30 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 5.96 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -22.89 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 7.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 429.50 Mn
10 Adlai Nortye 528.79 Mn 429.49 Mn - 22.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.23 Mn
Dec 31, 2025 37.22 Mn
Jun 30, 2025 53.73 Mn
Dec 31, 2024 36.48 Mn
Jun 30, 2024 49.89 Mn
Dec 31, 2023 13.75 Mn
Dec 31, 2022 12.81 Mn
API Access

Adlai Nortye Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=ANL&period=max&api_key=YOUR_API_KEY